The US Food and Drug Administration (FDA) has voluntarily recalled 101 products made by Strauss Israel for potential contamination with Salmonella.
Elite chocolate, cakes, chewing gum, energy chocolate rice cakes, energy grain snacks, and wafers are among the products recalled by Strauss.
The Elite items were distributed to stores in California, Connecticut, Florida, New Jersey, and New York. Amazon, Fresh Direct, Passover.com, and other online stores have also carried kosher chocolates. The FDA's website has a complete list of the products that have been recalled.
The impacted chocolates and candies were created in a facility where Salmonella was discovered in both the liquid chocolate used in the goods and on production line equipment, according to the FDA. Customers who have purchased the products can return them for a full refund, and any merchant who carries them has been requested to remove them from the sale. In addition to the 101 products recalled in the US, the Canadian Food Inspection Agency (CIFA) has discovered 97 potentially contaminated products on the Canadian market.
According to the Strauss Group, they decided to act fully responsibly, not to take any risks, and remove all the factory products from the shelves.
The company also apologized to the Israeli public, customers, and retailers for the difficulty, while thanking them for their patience and vow9ng to get back to all inquiries.
The recall was initially limited to "more than a dozen types of chocolate and chocolate used as raw ingredients," but it was later expanded to include Elite-brand items. Two out of 270 chocolate goods tested positive for salmonella when Strauss tested samples from its plant. Since then, manufacturing at the company's plant has been temporarily halted.
According to the FDA, no illnesses have been linked to the recall in the United States. In Israel, 21 people who consumed the contaminated products developed symptoms that were compatible with salmonella, and the country's Health Ministry took samples from them.


Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Thailand Inflation Remains Negative for 10th Straight Month in January
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



